Group 1 - The company, Lin Qingxuan, plans to globally offer 13.96645 million H-shares, with 1.39665 million shares available in Hong Kong and 12.5698 million shares for international offering, subject to reallocation and the exercise of the over-allotment option [1] - The offering price is set at HKD 77.77 per share, with a trading unit of 50 shares, and the shares are expected to start trading on the Hong Kong Stock Exchange on December 30, 2025 [1] - Lin Qingxuan is a high-end domestic skincare brand in China, focusing on anti-wrinkle and firming skincare products, and is known for its flagship brand offering high-end skincare solutions based on camellia oil [1] Group 2 - The company has entered into cornerstone investment agreements, with cornerstone investors agreeing to subscribe for shares at the offering price, totaling approximately USD 62 million (or about HKD 483 million) [2] - The cornerstone investors include Fidelity, Mega Prime Development Limited, LVC, Duckling Fund, SS Capital, and others, with a total of 620.47 million H-shares to be subscribed [2] Group 3 - The company estimates that the net proceeds from the global offering will be approximately HKD 997.1 million, assuming the over-allotment option is not exercised [3] - The proceeds will be allocated as follows: approximately 20% for brand value enhancement and promotion, 20% for expanding the sales network and establishing overseas channels, 15% for strengthening production and supply chain capabilities, 15% for technology R&D and product development, 15% for brand incubation and strategic acquisitions, 5% for digital and intelligent infrastructure, and 10% for working capital and general corporate purposes [3]

Core Viewpoint - Lin Qingxuan, a high-end domestic skincare brand in China, is set to launch an IPO from December 18 to December 23, 2025, offering 13.9665 million shares at a price of HKD 77.77 per share, with a market debut expected on December 30, 2025 [1][2]. Company Overview - Lin Qingxuan focuses on anti-wrinkle and firming skincare products, leveraging camellia oil as a key ingredient, and has established a strong market presence since its inception in 2012 [1][2]. - The company has developed a reputation for its "oil-based skincare" philosophy, with its first camellia oil essence launched in 2014, which has since become a cornerstone of its product line [1][2]. - Lin Qingxuan's camellia oil essence has ranked first in retail sales among all facial essence products in China for 11 consecutive years since 2014 [1]. Industry Insights - The Chinese skincare market has shown steady growth, with the market size increasing from RMB 332.9 billion in 2019 to an estimated RMB 461.9 billion by 2024, reflecting a compound annual growth rate (CAGR) of 6.8% [2]. - The high-end segment of the skincare market has experienced significant growth, rising from RMB 74.9 billion in 2019 to RMB 114.4 billion in 2024 [2]. - In 2024, Lin Qingxuan ranked 13th among all high-end skincare brands in China, holding a 1.4% market share, and is the only domestic brand in the top 15 [2]. - In the anti-wrinkle and firming product category, Lin Qingxuan ranked 10th among high-end brands, with a 2.2% market share, and is the leading domestic brand in this segment [2]. Fundraising and Use of Proceeds - The company has secured cornerstone investment agreements totaling approximately USD 62 million from various investors [3]. - The estimated net proceeds from the global offering are around HKD 997 million, which will be allocated as follows: 20% for brand value creation, 20% for enhancing the sales network, 15% for production and supply chain capabilities, 15% for R&D and product development, 15% for brand matrix expansion through internal incubation and external acquisitions, 5% for digital and intelligent infrastructure, and 10% for working capital and general corporate purposes [3].

Core Viewpoint - Lin Qingxuan is set to launch an IPO from December 18 to December 23, 2025, aiming to issue 13.9665 million shares at a price of HKD 77.77 per share, with a significant portion allocated for international investors [1] Company Overview - Lin Qingxuan is a high-end domestic skincare brand in China, focusing on anti-wrinkle and firming skincare products, known for its camellia oil-based solutions [1] - The company pioneered the "oil-based skincare" concept and launched its first camellia oil essence in 2014, which has since become a leading product in the facial essence market [1] - Lin Qingxuan has accumulated expertise in cell-level anti-wrinkle essence oil over more than a decade, with its camellia essence oil ranking first in retail sales among all facial essence products in China for 11 consecutive years since 2014 [1] Industry Insights - The Chinese skincare market has shown steady growth, with the market size increasing from RMB 332.9 billion in 2019 to RMB 461.9 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.8% [2] - The high-end segment of the skincare market has experienced significant growth, rising from RMB 74.9 billion in 2019 to RMB 114.4 billion in 2024 [2] - In 2024, Lin Qingxuan ranked 13th among all high-end skincare brands in China, holding a 1.4% market share, and is the only domestic brand in the top 15 [2] - In the anti-wrinkle and firming product segment, Lin Qingxuan ranked 10th among high-end skincare brands in China, with a 2.2% market share, and is the leading domestic brand in this category [2] Fundraising and Use of Proceeds - The company has secured cornerstone investment agreements with several funds, totaling approximately USD 62 million [3] - The estimated net proceeds from the global offering are around HKD 997 million, which will be allocated as follows: 20% for brand value creation, 20% for enhancing sales networks, 15% for production and supply chain capabilities, 15% for R&D and product development, 15% for brand matrix development through internal incubation and external acquisitions, 5% for digital and intelligent infrastructure, and 10% for working capital and general corporate purposes [3]

Core Viewpoint - Lin Qingxuan, a domestic beauty brand, is set to go public on the Hong Kong stock market after passing the listing hearing, marking a significant milestone in its growth trajectory [2]. Financial Performance - Lin Qingxuan's revenue surged from 691 million yuan in 2022 to 805 million yuan in 2023, and is projected to reach 1.21 billion yuan in 2024, reflecting a compound annual growth rate (CAGR) of 32.3% [2]. - The company turned a profit in 2023 with a net profit of 8.45 million yuan, a significant recovery from a loss of 5.93 million yuan in 2022, and is expected to further increase net profit by 121.1% to 187 million yuan in 2024 [2]. - In the first half of 2025, revenue increased by 93% year-on-year to 1.052 billion yuan, with net profit also rising by 120% to 182 million yuan, achieving a net profit margin of 17.3% and a gross margin of 82.4% [2]. Product Strategy - The brand's flagship product, Camellia Oil, has sold over 45 million bottles since its launch in 2014, contributing 45.5% of total revenue in the first half of 2025 [4]. - Lin Qingxuan's product line includes 230 SKUs, with Camellia Oil, cream, and lotion being the top three categories, accounting for approximately 15% and 10% of total revenue, respectively [4]. Marketing and Sales Strategy - Marketing expenses are high, with sales and distribution costs reaching 55.2% of total revenue in the first half of 2025, aligning with the overall trend in the domestic beauty industry [2][9]. - The company has significantly increased its online presence, with online sales accounting for over 65% of total revenue by the first half of 2025, up from 45.2% in 2022 [7]. Brand Development - Lin Qingxuan's brand narrative has evolved from small skincare products to a focus on high-end skincare, particularly emphasizing the benefits of Camellia Oil [5][6]. - The brand has undergone several strategic repositionings, most recently in 2023, to enhance its market presence as a "Camellia Anti-Aging Repair Expert" [5]. Market Outlook - The domestic beauty market is expected to see increased demand for plant-based oils, with analysts predicting a potential surge in interest in this segment over the next few years [9].

Core Insights - The company, Lin Qingxuan, is preparing for its IPO and has reported total revenue exceeding 1 billion RMB in the first half of 2025, indicating strong growth potential in the high-end skincare market [1][3]. Revenue and Growth - Lin Qingxuan's total revenue for the years 2022, 2023, and 2024 was 691.15 million, 805.00 million, and 1.21 billion RMB respectively, with a compound annual growth rate (CAGR) of 32.3% [3][4]. - In the first half of 2025, the company achieved a total revenue of 1.05 billion RMB, representing a year-on-year growth of approximately 98.5% [3][4]. Product Performance - The core product, Camellia Oil, has sold over 45 million bottles since its launch in 2014 and has ranked first in total retail sales among facial oils in China for 11 consecutive years [2][3]. - The contribution of the Camellia Oil to total revenue has increased from 31.5% in 2022 to 45.5% in the first half of 2025, highlighting its growing market competitiveness [4]. Market Position and Expansion - As of June 30, 2025, Lin Qingxuan operates 554 stores nationwide, with over 95% located in shopping malls, making it the leading domestic and international high-end skincare brand by store count in China [2][3]. - The company has diversified its product offerings to include 230 SKUs across various categories such as creams, toners, and sunscreens, aiming to mitigate risks associated with reliance on a single product [5]. Investment and Ownership - The founder, Sun Laichun, holds a 38.21% stake, while other notable investors include Yangtze River Fashion and Wu Xiaobo's fund, indicating strong backing from established investors [5].

Core Insights - The "oil-based skincare" trend is driving explosive growth in the skincare market, with the facial and eye serum oil market expected to grow from 5.19 billion yuan in 2023 to 7.75 billion yuan in 2024, a nearly 50% year-on-year increase, and projected to exceed 11 billion yuan by 2025 [29][30] - Estee Lauder's recent launch of the "Rejuvenating Platinum Oil" and its collaboration with the classic "Rejuvenating Cream" introduces a new "oil-cream synergy" that aims to redefine high-end oil-based skincare standards [29][30] Market Growth - The facial serum oil segment is the main category, with sales expected to reach 6.04 billion yuan in 2024 and 8.79 billion yuan in 2025 [29] - The industry is challenged to move beyond single oil products and explore new possibilities in ingredient synergy, scenario expansion, and value expression [29] Product Innovation - The "Rejuvenating Platinum Oil" features a unique "three-phase oil extract" that mimics the structure of young skin's lipid membrane, utilizing a scientific 3:7 water-oil ratio for enhanced absorption and anti-aging effects [32][33] - Estee Lauder's proprietary ingredient "Colorin™" activates key longevity genes, promoting protein regeneration and enhancing cellular energy levels by up to 33% [33] Skincare Logic - The proposed "oil first, cream second" skincare logic creates a moisture-locking barrier that prevents nutrient loss while continuously releasing anti-aging ingredients, achieving a closed-loop effect of "penetration - repair - retention" [33] - This strategy targets core consumer groups aged 25-45, addressing both early and mature aging concerns through a comprehensive coverage approach [33] Brand Strategy - The launch event featured a "White Moonlight Star Matrix" with global skincare ambassador Zhu Yilong and renowned actresses, transforming a traditional beauty launch into an artistic event that enhances brand value and market presence [35] - The collaboration emphasizes a shared philosophy between the brand and its ambassadors, focusing on a slow yet powerful approach to beauty that resonates with high-end consumers [42] Future Outlook - Estee Lauder's approach demonstrates that understanding local needs, innovating experiential scenarios, and conveying deeper values are essential for leading the high-end market [42] - The "oil-cream synergy" strategy not only addresses the limitations of single oil products but also opens new growth avenues through ingredient collaboration and sensory innovation, positioning the brand strategically in the high-end market [42]

Core Insights - Lin Qingxuan has successfully passed the Hong Kong Stock Exchange hearing and is set to become the first high-end domestic skincare stock listed on the main board [1] - The company has shown strong revenue growth, with total revenue projected to increase from 691 million yuan in 2022 to 1.21 billion yuan in 2024, representing a compound annual growth rate of 32.3% [1] - In the first half of this year, Lin Qingxuan achieved a revenue of 1.052 billion yuan, marking a year-on-year increase of 98.3% [1] Group 1: Market Position and Product Offerings - Lin Qingxuan has been the top-selling essence oil brand in China for 11 consecutive years, focusing on anti-wrinkle and firming skincare products [2] - The company pioneered the "oil-based skincare" concept in 2014 and has launched several successful products, including the Camellia Oil Essence, which has sold over 45 million bottles [2] - The product lineup includes various recognized items that cater to diverse consumer skincare needs, such as brightening creams and anti-wrinkle serums [2] Group 2: Sales Channels and Customer Engagement - Lin Qingxuan has effectively integrated online and offline sales channels, with a total of 554 stores nationwide, over 95% of which are located in shopping malls [2] - The company has achieved significant online sales success, ranking first in multiple categories on platforms like Tmall during major shopping events [3] - Lin Qingxuan has over 5.6 million active customers, with an average annual repurchase rate of approximately 33.5%, outperforming the industry average [3] Group 3: Research and Development - The company holds 87 patents, including 46 invention patents, covering key areas such as formula development and extraction technology [4] - Lin Qingxuan has established a complete value chain for its core ingredients, ensuring quality and uniqueness in its products [4] - The company has secured long-term supply agreements with nine high-quality camellia flower planting bases, ensuring a stable supply of raw materials [5] Group 4: Industry Trends and Future Outlook - The demand for high-end skincare products in China is steadily increasing, with a notable surge in demand for quality and effective products [6] - Lin Qingxuan is positioned to redefine high-end domestic skincare through its innovative approaches and comprehensive sales strategies [6] - The upcoming listing on the capital market is expected to enhance the brand's influence and drive further innovation in the domestic skincare sector [6]

来源：市场资讯 来源：独角兽IPO 林清轩的产品矩阵已从单一的山茶花精华油，扩展至覆盖全护肤流程的多元产品线。 上海林清轩化妆品集团股份有限公司（下称"林清轩"）于12月14日通过港交所上市聆讯，联席保荐人为 中信证券与华泰国际，标志着其向成为港股"国货高端护肤第一股"的目标迈出关键一步。 林清轩定位为国产高端护肤品牌，聚焦抗皱紧致市场，并以开创"以油养肤"理念及核心产品山茶花精华 油著称。 财务数据显示，林清轩业绩增长迅速：2025年上半年营收达10.52亿元，同比增长约98.5%；期内利润为 1.82亿元。2022年至2024年，公司营收从6.91亿元增长至12.10亿元，并于2023年实现扭亏为盈。 主要业务 林清轩的业务版图始于2003年，创始人孙来春在上海创立了该品牌。 品牌最初以手工皂等天然护肤产品为主，定位相对平易近人。 真正的转折点出现在2012年，当时品牌开始聚焦于山茶花护肤品的研究。两年后的2014年，首款山茶花 精华油面市，开创了品牌的"以油养肤"理念。 公司的业务呈现出鲜明特点与挑战。其核心大单品"山茶花精华油"累计销量已突破4500万瓶，并连续11 年位居全国面部精华油零售额榜首。根 ...

Core Viewpoint - Shanghai Linqingxuan Cosmetics Group Co., Ltd. is preparing for an IPO on the Hong Kong Stock Exchange, with the aim of raising funds for various strategic initiatives [1][2] Group 1: Fundraising Purpose - The funds raised from the IPO will be allocated to brand value creation and promotion, enhancing brand recognition and direct customer engagement [1] - Investment will be made to deepen the multi-channel sales network and establish overseas sales channels to increase market penetration [1] - The company plans to strengthen production and supply chain capabilities by upgrading existing skincare production facilities and establishing smart warehouse systems for better inventory management [1] - Funds will also support technological research and product development, including improvements and collaborations with leading research institutions [1] - The company aims to drive growth through both internal brand incubation and strategic acquisitions to create a brand matrix [1] - Investment in digital and intelligent infrastructure for operations and information systems will be prioritized [1] - A portion of the funds will be allocated for working capital and general corporate purposes [1] Group 2: Company Overview - Linqingxuan is a high-end domestic skincare brand in China, focusing on anti-wrinkle and firming products, with camellia oil as a core ingredient [2] - Since 2012, the company has developed a unique "oil-based skincare" philosophy, launching its first camellia oil essence in 2014, establishing a foundational product line [2] - Over more than a decade, the company has built expertise in cell-level anti-wrinkle essence oils and has created an integrated OMO sales network covering both online and offline channels [2] - As of June 30, 2025, the company plans to have 554 stores nationwide, covering major cities in China [2] - The company emphasizes research and development, holding multiple patents and core ingredient technologies, with a product range that includes essence oils, creams, lotions, and masks to meet comprehensive skincare needs [2]

Core Viewpoint - Lin Qingxuan is set to become the first high-end domestic skincare brand listed on the Hong Kong Stock Exchange, following its successful hearing and submission of post-hearing documents [1] Industry Overview - The Chinese cosmetics market is expanding, driven by increased consumer focus on health and appearance, digital transformation in shopping behavior, and a growing interest in healthier, high-quality products. Skincare products hold the largest market share, with the market size projected to grow from RMB 332.9 billion in 2019 to RMB 461.9 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.8% [1] Company Performance - Lin Qingxuan's total revenue is projected to grow from RMB 691 million in 2022 to RMB 1.21 billion in 2024, achieving a CAGR of 32.3%. In the first half of this year, the company reported revenue of RMB 1.052 billion, a year-on-year increase of 98.3%. The adjusted net profit for the same period rose by 117.4% to RMB 200 million, nearly matching the full-year profit for 2024, indicating strong growth momentum [2] - The market for high-end anti-wrinkle and firming skincare products is expected to increase from RMB 59.4 billion in 2024 to RMB 155.5 billion by 2029, with a CAGR of 21.2%. The overall high-end skincare industry in China is projected to reach RMB 218.5 billion by 2029, with a CAGR of 13.8% from 2024 to 2029 [2] Strategic Positioning - Lin Qingxuan is poised to benefit from its strong R&D capabilities and leading products. The company plans to enhance its product matrix and offer more customized skincare solutions for diverse applications, thereby strengthening brand recognition and leading the high-quality development of domestic beauty brands [3]